| Pharmaceutical Manufacturing | Production of ORS Powder, liquid orals, ointments, liquid externals, capsules, and tablets. | WHO GMP certification, diversified portfolio, new manufacturing capacity, and direct export presence. | B2B customers including pharmaceutical distributors, healthcare providers, and retail chains. | Tablets and capsules expected to increase profit margins. | 133 | 100 | Sales of pharmaceutical formulations to domestic and export customers. | Direct sales with negotiated pricing for bulk orders; new tablet segment under development. | New product lines, WHO GMP certification, manufacturing expansion, and direct exports. | BVM's Oral Rehydration Salts B.P. 27.9g |
